Transgenic animal with recombinant vascular endothelial growth factor b (vegf-b) dna and uses thereof
CA 2279573 A1 · Owner: Ludwig Institute For Cancer Research · Inventors: Pekny, Milos; Eriksson, Ulf; Li, Xuri
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Transgenic animals containing recombinant DNA with modified nucleotide sequence from the vascular endothelial growth factor B (VEGF-B) gene cells , and methods for producing such animals and methods of using them to assay , substances for VEGF-B-like activity.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 18, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended February 18, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 18, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.